Fig. 4From: Five-year outcomes after IVIG for mild cognitive impairment due to alzheimer diseaseMMSE (Panel A), ADAS-Cog (Panel B), and CDR-SB (Panel C) at baseline and 1, 2, 3, 4, and 5 years following IVIG or placeboBack to article page